Abstract
Loss of hormone receptor (HR) status in breast carcinomas is associated with increased tumour cell motility and invasiveness. In an immunohistological study of 58 primary breast cancers, oestrogen (ER) and progesterone (PR) receptor levels were inversely correlated with the expression of fascin, an actin-bundling protein associated with cell motility (P< 0.0001 and P = 0.0019, respectively). In addition, fascin was preferentially expressed in non-diploid tumours (P = 0.03). In summary, the upregulation of fascin in HR-negative breast cancers may contribute to their more aggressive behaviour. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adams JC, Clelland JD, Collett GD, Matsumura F, Yamashiro S and Zhang L (1999) Cell–matrix adhesions differentially regulate fascin phosphorylation. Mol Biol Cell 10: 4177–4190
Amieva MR and Furthmayr H (1995) Subcellular localization of moesin in dynamic filopodia, retraction fibers, and other structures involved in substrate exploration, attachment, and cell–cell contacts. Exp Cell Res 219: 180–196
Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL and Asch BB (1996) Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 56: 4841–4845
Ben-Ze'ev A (1985) The cytoskeleton in cancer cells. Biochim Biophys Acta 780: 197–212
Carmeci C, Thompson DA, Kuang WW, Lightdale N, Furthmayr H and Weigel RJ (1998) Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. Surgery 124: 211–217
del Peso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C and Lacal JC (1997) Rho proteins induce metastatic properties in vivo. Oncogene 15: 3047–3057
Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet 339: 1–15
Edwards RA and Bryan J (1995) Fascins, a family of actin bundling proteins. Cell Motil Cytoskeleton 32: 1–9
Gluck U, Kwiatkowski DJ and Ben-Ze'ev A (1993) Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with α-actinin cDNA. Proc Natl Acad Sci USA 90: 383–387
Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW, Yu D, Mooney EE and McCrea PD C-erbB-02/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility in human breast cancer cell lines. Oncogene,
Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, Yamada Y, Chiba H and Hirohashi S (1998) Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383–1393
Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LCJM and Collard JG (1997) Inhibition of inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278: 1464–1466
Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R and Sutherland RL (1997) EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 15: 1617–1623
Jordan VC, Wolf MF, Mirecki DM, Whitford DA and Welshons WV (1988) Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast. Crit Rev Clin Lab Sci 26: 97–152
Kantor JD and Zetter BR (1996) Cell motility in breast cancer. Cancer Treat Res 83: 303–323
Keely PJ, Westwick JK, Whitehead IP, Der CJ and Parise LV (1997) Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through Pl(3)K. Nature 390: 632–636
Knight WA, Livingston RB, Gregory EJ and McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Leclercq G, Bojar H, Goussard J, Nicholson RI, Pichon MF, Piffanelli A, Pousette A, Thorpe S and Lonsdorfer M (1986) Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. Cancer Res 46: 4233s–4236s
Mitchison TJ and Cramer LP (1996) Actin-based cell motility and cell locomotion. Cell 84: 371–379
Otto JJ (1994) Actin-bundling proteins. Curr Opin Cell Biol 6: 105–109
Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G and Said JW (1997) Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am J Pathol 150: 543–562
Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S and Garcia M (1998) Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 65: 163–168
Rodriguez Fernandez JL, Geiger B, Salomon D, Sabanay I, Zoller M and Ben-Ze'ev A (1992) Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J Cell Biol 119: 427–438
Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D and Olsson H (1990) Indicators of prognosis in node-negative breast cancer. N Engl J Med 322: 1045–1053
Tilney LG, Tilney MS and Guild GM (1995) F actin bundles in Drosophila bristles. I. Two filament cross-links are involved in bundling. J Cell Biol 130: 629–638
Vindelow L, Christensen I and Nissen N (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323–327
Wong V, McCrea PD and Firestone GL (1997) Fascin protein down regulation is required for glucocortiocoid-induced adherens and tight junctions formation in mammary epithelial cells. Mol Biol Cell 7,
Yamashiro S, Yamakita Y, Ono S and Matsumura F (1998) Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 9: 993–1006
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Grothey, A., Hashizume, R., Sahin, A. et al. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 83, 870–873 (2000). https://doi.org/10.1054/bjoc.2000.1395
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1395
Keywords
This article is cited by
-
Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy
Medical Molecular Morphology (2023)
-
Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence
Molecular Diagnosis & Therapy (2019)
-
Fascin phosphorylation sites combine to regulate esophageal squamous cancer cell behavior
Amino Acids (2017)
-
Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer
Virchows Archiv (2016)
-
Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization
Nature Communications (2015)